Building a 21st Century Learning Space in North Chicago

AbbVie is donating $40 million to rebuild the only middle school in our backyard of North Chicago, creating a safe and welcoming environment for students.

Read the announcement

Our Journey of Impact

Come with us as we remember where we’ve been, and look forward to where we’re going.

Learn More

Latest News

If you are a member of the news media and have questions or need additional information, please contact our Communications Team.

Apr 17, 2019

AbbVie Announces Call for Entries for the AbbVie CF Scholarship for the 2019-2020 Academic School Year

Apr 03, 2019

AbbVie to Host First-Quarter 2019 Earnings Conference Call

Mar 26, 2019

AbbVie Announces First Regulatory Approval of SKYRIZI™ (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis and Psoriatic Arthritis in Japan

Mar 21, 2019

AbbVie Donates $40 Million to Rebuild North Chicago Middle School
Read More

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?